Clin2
NCT07490535Possibly a fitNot yet recruiting

Xiidra eye drops effect on tear markers in dry eye

Ocular Surface DiseaseDry Eye Syndrome (DES)

Part of Eyes & vision clinical trials.

This study looks at how Xiidra eye drops affect natural tear markers in people with dry eye. It also compares them to a small group of people without dry eye. If you have moderate dry eye and are already using Xiidra (or you do not have dry eye and want to help as a volunteer), you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
36 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You have had dry eye disease in both eyes for at least 6 months (if using Xiidra) OR you do not have dry eye disease (if you are a healthy volunteer).
  • You are willing to avoid other eye drops for 2 hours before each study visit.
  • You agree to stop wearing contact lenses during the whole study.
  • If you are of childbearing potential, you are willing to use approved birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04354545Recruiting
Testing treatments for eye discomfort in glaucoma

This trial studies how to treat eye surface discomfort in people who have glaucoma and are already using multiple eye drops. It may help reduce symptoms like irritation while keeping glaucoma treatment on track.

Fountain Valley, California
NCT07593404Recruiting
Testing a New Eye Drop for Dry Eye Disease

This study tests a new lubricating eye drop designed to relieve dry eye symptoms. If you have dry eye disease, this trial may help determine if the new formula works better than what's currently available.

Waterloo, Ontario
NCT07560735Not yet recruiting· Phase 4
Lifitegrast eye drops for dry eye disease evaluation

This study tests whether lifitegrast eye drops (a medication that reduces eye inflammation) help people with moderate to severe dry eye disease. Researchers will use a special microscope to examine your eye surface before and after treatment.

Nashville, Tennessee
NCT07267481Not yet recruiting· Phase 4
Switching from Xiidra to a new dry eye drop

This study tests if switching from Xiidra to another dry eye drop (TRYPTYR) works better for people with dry eye disease. You may qualify if Xiidra isn't helping enough and you've been using it for at least a month.

NCT06879782Recruiting· Phase 3
Eye drops for dry eye disease: a phase 3 study

This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.

Beijing, Beijing Municipality
NCT07369375Not yet recruiting
Testing New Eye Drops for Dry Eye Disease

This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.

Hear when a new Ocular Surface Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.